ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer

By sjmartinez • June 28, 2024

Qian C, Yang Q, Rotinen M, Huang R, Kim H, Gallent B, Yan Y, Cadaneanu RM, Zhang B, Kaochar S, Freedland SJ, Posadas EM, Ellis L, Di Vizio D, Morrissey C, Nelson PS, Brady L, Murali R, Campbell MJ, Yang W, Knudsen BS, Mostaghel EA, Ye H, Garraway IP, You S, Freeman MR. ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer. Nucleic Acids Res. 2024 Jun 27:gkae547. doi: 10.1093/nar/gkae547. Epub ahead of print. PMID: 38932701.

Tags: Cedars Sinai DoM, General Internal Medicine, Publications

Sustained Effects of a 6-Week Resiliency Program for Women with Metastatic Breast Cancer: A Brief Report of a Clinical Trial

Henneghan A, Wertheimer J, Kim S, Gresham G, Shirazipour CH, Jones B, Asher A. Sustained Effects of a 6-Week Resiliency Program for Women with Metastatic[...]

CalShock: beyond the shock team, building on California’s cardiogenic shock system of care

Bell FM, Holtzman JN, Chandrakumar HP, Marogi EP, Khedraki R, Cheng R, Elliott A, Hilliard AA, Itchhaporia D, Chonde MD, Naidu SS, Egrie G, Mahmud[...]

Strategies for promoting exercise adherence within a cancer exercise recovery program: a qualitative case study

Huynh N, Cruz N, Torney C, Ruggieri R, Chang P, Asher A, Shirazipour CH. Strategies for promoting exercise adherence within a cancer exercise recovery program:[...]